Edition:
United Kingdom

Pharmaceuticals

Page 1

Jubilant Life Sciences To Consider To Create Separate Entities For Pharmaceuticals And Life Science Ingredients Businesses

Friday, 26 Jul 2019

July 26 (Reuters) - Jubilant Life Sciences Ltd ::CONSIDER TO CREATE SEPARATE AND FOCUSED ENTITIES FOR PHARMACEUTICALS AND LIFE SCIENCE INGREDIENTS BUSINESSES.

Perrigo Company PLC Reports Q1 Earnings Per Share $0.47

Wednesday, 8 May 2019

May 8 (Reuters) - Perrigo Company PLC ::REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS, BEGINS CONSUMER SELF-CARE TRANSFORMATION.Q1 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.07.Q1 EARNINGS PER SHARE $0.47.Q1 EARNINGS PER SHARE ESTIMATE $1.16 -- REFINITIV IBES DATA.Q1 SALES $1.2 BILLION VERSUS REFINITIV IBES ESTIMATE OF $1.21 BILLION.PERRIGO COMPANY - DOES NOT EXPECT ANY FURTHER CONTRIBUTIONS FROM INFANT FOODS PRODUCT LINE GOING FORWARD..QTRLY GAAP NET SALES DOWN 1% EXCLUDING UNFAVORABLE IMPACT OF CURRENCY..PERRIGO WORLDWIDE CONSUMER SEGMENTS Q1 REPORTED NET SALES OF $933 MILLION, DOWN 5% YEAR-OVER-YEAR.UPDATED ITS REPORTING SEGMENTS.WILL HOLD ITS INVESTOR DAY MAY 9 TO DISCUSS ITS STRATEGY AS WELL AS 2019 GUIDANCE AND KEY GROWTH OPPORTUNITIES.ISRAELI DIAGNOSTIC BUSINESS WAS MOVED FROM CONSUMER SELF-CARE INTERNATIONAL SEGMENT TO RX SEGMENT.

Polyphor's Shareholders Approve All Motions Proposed At AGM

Friday, 12 Apr 2019

April 12 (Reuters) - POLYPHOR AG ::SHAREHOLDERS APPROVE ALL MOTIONS PROPOSED BY THE BOARD OF DIRECTORS AT THE ANNUAL GENERAL MEETING.

Glaxo Smithkline Consumer Nigeria Selects Fidson Healthcare As Local Contract Manufacturing Partner

Friday, 12 Apr 2019

April 12 (Reuters) - Glaxo Smithkline Consumer Nigeria Plc: :SELECTION OF FIDSON HEALTHCARE AS LOCAL CONTRACT MANUFACTURING PARTNER AS PART OF RESTRUCTURING OF SUPPLY CHAIN MODEL.WILL BE TRANSITIONING MANUFACTURING OF ITS WELLNESS, RESPIRATORY PRODUCTS IN FIRST INSTANCE TO FIDSON FROM Q3, 2021.

Glaxo Smithkline Consumer Nigeria Selects Fidson Healthcare As Local Contract Manufacturing Partner

Friday, 12 Apr 2019

April 12 (Reuters) - Glaxo Smithkline Consumer Nigeria Plc: :SELECTION OF FIDSON HEALTHCARE AS LOCAL CONTRACT MANUFACTURING PARTNER AS PART OF RESTRUCTURING OF SUPPLY CHAIN MODEL.WILL BE TRANSITIONING MANUFACTURING OF ITS WELLNESS, RESPIRATORY PRODUCTS IN FIRST INSTANCE TO FIDSON FROM Q3, 2021.

Kyowa Hakko Kirin Co Announces Results Of Early Retirement Offer

Wednesday, 10 Apr 2019

April 10 (Reuters) - Japan's Kyowa Hakko Kirin Co Ltd <4151.T>::ANNOUNCES RESULTS OF EARLY RETIREMENT OFFER.296 EMPLOYEES ACCEPTED OFFER TO RETIRE VOLUNTARILY EFFECTIVE JUNE 30.SEVERANCE AND OUTPLACEMENT EXPENSES TO BE ABOUT 5.1 BILLION YEN, RECORDED AS 'OTHER EXPENSES' IN Q1.CONSOLIDATED FORECASTS REMAIN UNCHANGED.

GT Biopharma Names Anthony J Cataldo As Chief Executive Officer

Tuesday, 26 Mar 2019

March 26 (Reuters) - GT Biopharma Inc ::GT BIOPHARMA ANNOUNCES COMPLETION OF MANAGEMENT RESTRUCTURING.GT BIOPHARMA INC - ANTHONY J CATALDO HAS BEEN NAMED CHAIRMAN AND CHIEF EXECUTIVE OFFICER.GT BIOPHARMA INC - STEVEN WELDON HAS BEEN APPOINTED AS CHIEF FINANCIAL OFFICER AND A MEMBER OF BOARD.

Kyowa Hakko Kirin Co Offer Of Voluntary Early Retirement

Tuesday, 5 Feb 2019

Kyowa Hakko Kirin Co Ltd <4151.T>::OFFER OF VOLUNTARY EARLY RETIREMENT.TARGET NUMBER OF APPLICANTS NOT SPECIFIED.

Cv Sciences Inc Announces The Retirement Of Its Founder And Management Restructure

Tuesday, 22 Jan 2019

Jan 22 (Reuters) - CV Sciences Inc ::CV SCIENCES, INC. ANNOUNCES THE RETIREMENT OF ITS FOUNDER AND MANAGEMENT RESTRUCTURE.CV SCIENCES - ELIMINATED TITLE OF PRESIDENT, AND MICHAEL MONA III, WILL CONTINUE AS COMPANY'S CO-FOUNDER AND CHIEF OPERATING OFFICER.

Markets

  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary